The Regulatory Center

Filter Your Results

 

News

 

CMS Will Cover Boston Scientific’s Watchman LAAC Device

February 8, 2016 -- Boston Scientific Corporation announced that the US Centers for Medicare and Medicaid Services (CMS) will cover percutaneous left atrial appendage closure …

FDA Issues Draft Guidance on “Emerging Signals” Notifications for Medical Devices

January 5, 2016 -- The US Food and Drug Administration (FDA) announced last week the availability of a draft guidance entitled, “Public Notification of Emerging Pos…

FDA Approves Zoll’s LifeVest Defibrillator for Children at Risk for Sudden Cardiac Arrest

December 22, 2015 -- The US Food and Drug Administration (FDA) announced last week that it approved a new indication for the LifeVest wearable cardioverter defibrillator (Zoll…

Industry Groups Applaud 2-Year Suspension of Medical Device Tax

December 21, 2015 -- President Obama signed the $1.1 trillion omnibus budget bill into law that includes a 2-year suspension of the medical device excise tax in 2016 and 2017.…

Boehringer Ingelheim’s Praxbind Approved in Europe for Reversal of Pradaxa

November 26, 2015 -- Boehringer Ingelheim Pharmaceuticals announced that the European Commission has approved Praxbind (idarucizumab), a treatment to rapidly and specifically …

FDA Issues Safety Communication on Lubricious Coating Separation in Intravascular Medical Devices

November 23, 2015 -- The US Food and Drug Administration (FDA) issued a safety communication regarding lubricious coating separation on medical devices, including intrava…

CE Mark Approved for Boston Scientific’s Next-Generation Watchman FLX LAA Closure Device

November 19, 2015 -- Boston Scientific announced European CE Mark approval for the Watchman FLX left atrial appendage (LAA) closure device. Commercialization of the Watchman F…

FDA Approves Study for Next-Generation TherOx SSO2 Therapy for AMI

November 5, 2015 -- TherOx, Inc. announced it has received US Food and Drug Administration (FDA) investigational device exemption approval for a confirmatory safety study of a…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.